Your browser doesn't support javascript.
loading
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.
Balaña, C; Estival, A; Teruel, I; Hardy-Werbin, M; Sepulveda, J; Pineda, E; Martinez-García, M; Gallego, O; Luque, R; Gil-Gil, M; Mesia, C; Del Barco, S; Herrero, A; Berrocal, A; Perez-Segura, P; De Las Penas, R; Marruecos, J; Fuentes, R; Reynes, G; Velarde, J M; Cardona, A; Verger, E; Panciroli, C; Villà, S.
Affiliation
  • Balaña C; Medical Oncology Service, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Ctra Canyet, s/n, 08916, Badalona (Barcelona), Spain. cbalana@iconcologia.net.
  • Estival A; Medical Oncology Service, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Ctra Canyet, s/n, 08916, Badalona (Barcelona), Spain.
  • Teruel I; Medical Oncology Service, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Ctra Canyet, s/n, 08916, Badalona (Barcelona), Spain.
  • Hardy-Werbin M; Cancer Research Programm, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Sepulveda J; Medical Oncology Service, Hospital Universitario, 12 de Octubre, Madrid, Spain.
  • Pineda E; Medical Oncology Service, Hospital Clinic Provincial, Barcelona, Spain.
  • Martinez-García M; Medical Oncology Service, Hospital del Mar, Barcelona, Spain.
  • Gallego O; Medical Oncology Service, Hospital de Sant Pau, Barcelona, Spain.
  • Luque R; Medical Oncology Service, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Gil-Gil M; Medical Oncology Service, Institut Català d'Oncologia-IDIBELL, Hospitalet de Llobregat, Spain.
  • Mesia C; Medical Oncology Service, Institut Català d'Oncologia-IDIBELL, Hospitalet de Llobregat, Spain.
  • Del Barco S; Medical Oncology Service, Institut Català d'Oncologia, Hospital Josep Trueta, Girona, Spain.
  • Herrero A; Medical Oncology Service, Hospital Miguel Servet, Saragossa, Spain.
  • Berrocal A; Medical Oncology Service, Hospital General Universitario de Valencia, Valencia, Spain.
  • Perez-Segura P; Medical Oncology Service, Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • De Las Penas R; Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain.
  • Marruecos J; Radiation Oncology Service, Institut Català d'Oncologia, Hospital Josep Trueta, Girona, Spain.
  • Fuentes R; Radiation Oncology Service, Institut Català d'Oncologia, Hospital Josep Trueta, Girona, Spain.
  • Reynes G; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain.
  • Velarde JM; Institut Investigació Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Badalona, Spain.
  • Cardona A; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia.
  • Verger E; Foundation for Clinical and Applied Cancer Research, FICMAC, Bogotá, Colombia.
  • Panciroli C; Biology Systems Department, Universidad el Bosque, Bogotá, Colombia.
  • Villà S; Radiation Oncology Service, Hospital Clinic Provincial, Barcelona, Spain.
Clin Transl Oncol ; 20(12): 1529-1537, 2018 Dec.
Article in En | MEDLINE | ID: mdl-29737461

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy / Brain Neoplasms / Chemotherapy, Adjuvant / Glioblastoma / Time-to-Treatment Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Transl Oncol Year: 2018 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy / Brain Neoplasms / Chemotherapy, Adjuvant / Glioblastoma / Time-to-Treatment Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Transl Oncol Year: 2018 Type: Article Affiliation country: Spain